This inventor holds 1 USPTO granted patent. Top assignee: Senju Pharmaceutical Co., Ltd.. Active years: 1986.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1986
Title: Takashi Awata: Innovator in Ophthalmic Treatments
Introduction
Takashi Awata is a notable inventor based in Amagasaki, Japan. He has made significant contributions to the field of ophthalmology through his innovative research and development. His work focuses on creating effective treatments for diseases affecting the iris and ciliary body.
Latest Patents
Awata holds a patent for an ophthalmic topical agent designed to remedy diseases of the iris and ciliary body. This agent contains 5-(3-ethoxy-4-pentyloxyphenyl)-2,4-thiazolidinedione or its physiologically acceptable salt as an active ingredient. This invention showcases his commitment to advancing medical treatments and improving patient outcomes.
Career Highlights
Throughout his career, Awata has been associated with Senju Pharmaceutical Co., Ltd., a company known for its dedication to ophthalmic research and development. His work has contributed to the company's reputation as a leader in the field.
Collaborations
Awata has collaborated with esteemed colleagues such as Yutaka Kawamatsu and Tomio Maenaka. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Takashi Awata's contributions to ophthalmology through his patent and collaborations highlight his role as an influential inventor in the medical field. His work continues to pave the way for advancements in treatments for eye diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile